🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
68.45
+0.73 (1.08%)
At close: Nov 20, 2026, 4:00 PM EST
67.65
-0.80 (-1.17%)
After-hours: Nov 20, 2026, 7:48 PM EST

Royalty Pharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
672.45770.95858.981,13542.83619.73
Depreciation & Amortization
4.883.85--5.6723
Other Amortization
31.2128.6419.5620.521.3620.16
Asset Writedown & Restructuring Costs
219.8---615.83-
Loss (Gain) From Sale of Investments
-0.84-24.01-194.46-317.9840.2630.21
Loss (Gain) on Equity Investments
-6.45-15.69-16.22-10.0648.1253.87
Stock-Based Compensation
459.71289.892.342.362.172.44
Provision & Write-off of Bad Debts
5.52-295.84732.46560.66904.24452.84
Other Operating Activities
-1,946-1,606-1,670-1,609-2,076-1,484
Change in Accounts Receivable
3,5763,3552,9833,2012,5072,296
Change in Accounts Payable
-32.96-13.93-2.296.242.29-4.59
Change in Other Net Operating Assets
-23.4-3.2255.67-0.8530.388.4
Operating Cash Flow
2,9602,4902,7692,9882,1442,018
Operating Cash Flow Growth
23.06%-10.08%-7.32%39.36%6.27%-0.84%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Acquisitions
--74.42----
Sale (Purchase) of Intangibles
-1,716-1,698-2,506-2,116-1,742-2,192
Investment in Securities
-58.54438.22-99.4557.17712.22339.82
Other Investing Activities
-66.44-280.26-72.96-14.44--18.6
Investing Cash Flow
-1,841-1,614-2,678-2,073-1,029-1,870

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-1,275-350--
Long-Term Debt Issued
-1,9541,471--1,273
Total Debt Issued
503,2291,471350-1,273
Short-Term Debt Repaid
--1,275--350--
Long-Term Debt Repaid
--1,000--1,000--
Total Debt Repaid
-430-2,275--1,350--
Net Debt Issued (Repaid)
-380954.481,471-1,000-1,273
Repurchase of Common Stock
-261.62-1,227-229.65-304.76--
Common Dividends Paid
-408.87-378.25-376.47-358.33-333.32-285.18
Other Financing Activities
-493.67-534.81-503.97-485.67-611.53-602.24
Financing Cash Flow
-1,544-1,186361.15-2,149-944.86385.11

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-425.29-310.33452.02-1,234169.7532.37

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Levered Free Cash Flow
-450.27-670.41-1,758-1,244-1,384-1,547
Unlevered Free Cash Flow
-240.73-500.56-1,636-1,148-1,288-1,463

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
358.4276.29159.57169.17170.14130.43
Change in Working Capital
3,5203,3383,0373,2072,5402,300
SEC Filings: 10-K · 10-Q